Flatrock Portfolio Diversification
Flatrock Wealth Partners Expands Diversified Portfolio with Key New Stakes in Q1
Anonymous
Key Points
1
Merck stock fundamentals at the time of Flatrock's stake include an opening price of $128.87, a 52-week range of $76.66 to $130.29, a market capitalization of about $318.28 billion, a P/E ratio of 36.30, a PEG of 2.71, and a beta of 0.19.
2
Several equities researchers raised price targets on Citigroup after Flatrock disclosed its new stake, including Barclays at $154, Bank of America at $176, Royal Bank of Canada at $139, and Truist Financial at $158, signaling bullish sentiment toward the stock.
3
Flatrock's completed trade in SPDR Bloomberg 1-3 Month T-Bill ETF (BIL) positions the fund at 96,817 shares, about 4% of Flatrock's holdings, making it the seventh-largest position in the portfolio.
4
Flatrock added 26,616 shares of iShares MSCI USA Min Vol Factor ETF (USMV), valued around $2.468 million, representing roughly 1.1% of its portfolio and ranking as the 21st biggest holding.
Flatrock Wealth Partners LLC quietly built a broad new portfolio in the first quarter, snapping up positions across stocks, ETFs, and fixed-income proxies. The firm's biggest single move was a 96,817-share stake in the SPDR Bloomberg 1-3 Month T-Bill ETF, worth roughly $8.9 million, according to Watchlist News.
The purchases span sectors from healthcare to financial services to low-volatility equities. Together, they paint a picture of a firm building a diversified institutional portfolio from the ground up.
T-Bill ETF Anchors Flatrock's New Fixed-Income Tilt
The BIL position is Flatrock's seventh-largest holding and makes up about 4% of its total portfolio, per Watchlist News. BIL tracks 1-to-3-month U.S. Treasury bills. It gives investors near-cash returns with very low risk. The move signals that Flatrock wants a cushion of short-term, safe assets alongside its equity bets.
Flatrock also added 33,282 shares of Vanguard Long-Term Treasury ETF, worth about $1.84 million, according to Watchlist News. That pairing — short-term T-bills plus long-term Treasuries — suggests the firm is hedging across the yield curve rather than betting on one direction for rates.
Citigroup Stake Arrives Amid Bullish Analyst Price Targets
Flatrock bought 4,535 Citigroup shares for about $514,000 in Q1, according to Watchlist News. The timing aligned with a wave of bullish analyst calls on the stock. Barclays set a price target of $154. Bank of America went higher at $176. Royal Bank of Canada came in at $139, and Truist Financial set its target at $158.
Those targets suggest analysts see meaningful upside in Citigroup from where Flatrock entered. The financial sector pick rounds out what appears to be a deliberate diversification strategy across growth, value, and income plays.
Merck and QQQ Round Out Equity Exposure
Flatrock picked up 4,703 shares of Merck for about $570,000. Merck's stock carried a P/E ratio of 36.30 and a market cap of roughly $318 billion at the time. Its beta of 0.19 makes it one of the steadier large-cap names on the market — barely moving compared to the broader index.
The firm also bought 1,600 shares of Invesco QQQ, valued at around $924,000. QQQ tracks the Nasdaq-100, giving Flatrock exposure to high-growth tech names. It also added 5,010 shares of Ciena Corporation for about $1.945 million, per Ticker Report, further broadening its equity reach into networking technology.
Low-Volatility ETF and Vanguard S&P 500 Add Defensive Core
Flatrock added 26,616 shares of iShares MSCI USA Min Vol Factor ETF, known as USMV, worth about $2.47 million. That stake is its 21st-largest holding and equals about 1.1% of its total portfolio. USMV picks U.S. stocks designed to swing less than the broader market — a classic defensive play.
The firm also bought 3,254 shares of Vanguard S&P 500 ETF for about $1.94 million, making it the 27th-largest holding, according to Watchlist News. Taken together, Flatrock's Q1 moves suggest a firm building a core-and-satellite portfolio: safe bonds and broad index funds at the center, with targeted bets in healthcare, financials, and tech around the edges.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
20
Articles
9
Reach
29
A
AnonymousAuthor
